CBL ASX Chart
Snapshot
Control Bionics Limited (CBL) is a medical device company assisting patients whose ability to communicate verbally or via text and social media is compromised by illnesses such as Motor Neurone Disease (MND) and Amyotrophic Lateral Sclerosis (ALS). Control Bionics operates in North America, Australia, Singapore and Japan.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2025 YTD | |
1 Year | |
vs Sector (1yr) | - |
vs ASX 200 (1yr) | -0.09% |
Announcements
Corporate Overview
Corporate Details
Head Office | Cremorne VIC 3121 |
Website | www.controlbionics.com |
Registry | Automic Group |
Auditor | BDO Audit Pty Ltd |
Date Listed | 7 Dec 2020 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
26/02/2025 | Report (Interim) |
27/08/2025 | Report (Prelim) |
27/08/2025 | Report (Annual) |
Former Company Names
- Control Bionics Ltd has no former company names.
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Key Data | |
---|---|
DPS(TTM) | $0.00 |
Gross DPS(TTM) | $0.00 |
Dividend yield |
|
Gross yield |
|
Payout Ratio | -- |
DRP | No |
DRP Features | - |
Directors & Management
Directors
Management
Director Transactions
CBL directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of CBL directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
Phoenix Development Fund Limited | 02/08/2024 | 31,269,581 | 18.20 |
Peter Shann Ford | 02/08/2024 | 20,003,433 | 10.04 |
Nightingale Partners Pty Limited | 16/10/2024 | 33,480,280 | 13.52 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
Date | Name | Bought | Previous % | New % |
---|---|---|---|---|
16-10-24 | Nightingale Partners Pty Limited | 12,192,685 | 12.47 | 13.52 |
03-06-24 | Peter Shann Ford | 100,000 | 11.50 | 9.89 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
Date | Name | Sold | Previous % | New % |
---|---|---|---|---|
16-10-24 | Craig Chapman | 10,000,000 | 5.86 | -- |
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2024 | $0.052 | 28 June |
2023 | $0.087 | 30 June |
2022 | $0.225 | 30 June |
2021 | $0.695 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.